WARNING: This product is for research use only, not for human or veterinary use.
Hodoodo CAT#: H461222
CAS#: 3625-25-0
Description: Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.
Hodoodo Cat#: H461222
Name: Reposal
CAS#: 3625-25-0
Chemical Formula: C14H18N2O3
Exact Mass: 262.13
Molecular Weight: 262.300
Elemental Analysis: C, 64.11; H, 6.92; N, 10.68; O, 18.30
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @hodoodo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: Reposal; Reposal novo; Reposamal; WT161; WT-161; WT 161;
IUPAC/Chemical Name: 5-(bicyclo[3.2.1]oct-2-en-3-yl)-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
InChi Key: MKELYWOVSPVORM-UHFFFAOYSA-N
InChi Code: InChI=1S/C14H18N2O3/c1-2-14(11(17)15-13(19)16-12(14)18)10-6-8-3-4-9(5-8)7-10/h6,8-9H,2-5,7H2,1H3,(H2,15,16,17,18,19)
SMILES Code: O=C1NC(C(CC)(C2=CC(C3)CCC3C2)C(N1)=O)=O
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: Soluble in DMSO
Shelf Life: >3 years if stored properly
Drug Formulation: This drug may be formulated in DMSO
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.03.00
More Info:
Biological target: | |
In vitro activity: | |
In vivo activity: |
The following data is based on the product molecular weight 262.30 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
Formulation protocol: | |
In vitro protocol: | |
In vivo protocol: |
1: KESSING SV, TARDING F, THOMSEN AC. [REPOSAL, A NEW HYPNOTIC. II. CLINICAL EFFECTS]. Ugeskr Laeger. 1963 Dec 6;125:1739-41. Danish. PubMed PMID: 14103837.
2: KESSING SV, TARDING F, THOMSEN AC. [REPOSAL, A NEW HYPNOTIC. I. PHARMACODYNAMIC ACTIVITY]. Ugeskr Laeger. 1963 Dec 6;125:1735-8. Danish. PubMed PMID: 14103836.
3: Nielsen P, Tarding F. The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal). Acta Pharmacol Toxicol (Copenh). 1968;26(6):521-30. PubMed PMID: 5756387.